(株)医学生物学研究所の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証JQS | 医薬品 | 4557/E00978 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2019/12/13 | 日証協 | 158,821株 | +73.11% | 113,300株 | +412.67% | 89,791株 | +25.73% | 41,200株 | +186.11% |
2019/12/06 | 日証協 | 91,745株 | +11.99% | 22,100株 | +95.58% | 71,415株 | -4.77% | 14,400株 | +41.13% |
2019/11/29 | 日証協 | 81,924株 | -17.35% | 11,300株 | -67.06% | 74,994株 | -12.68% | 10,203株 | +43.06% |
2019/11/22 | 日証協 | 99,124株 | +30.21% | 34,300株 | +22.5% | 85,889株 | -2.05% | 7,132株 | +20.88% |
2019/11/15 | 日証協 | 76,124株 | -40.31% | 28,000株 | -52.14% | 87,686株 | -28.88% | 5,900株 | -88.54% |
2019/11/08 | 日証協 | 127,524株 | -35.8% | 58,500株 | -75.49% | 123,292株 | -40.04% | 51,500株 | -12.85% |
2019/11/01 | 日証協 | 198,624株 | +26.75% | 238,700株 | +262.06% | 205,623株 | +24.93% | 59,095株 | +636.94% |
2019/10/25 | 日証協 | 156,700株 | -12.57% | 65,929株 | -56.16% | 164,595株 | -12.22% | 8,019株 | -78.8% |
2019/10/18 | 日証協 | 179,221株 | +31.54% | 150,376株 | +88.66% | 187,500株 | +19.14% | 37,830株 | -11% |
2019/10/11 | 日証協 | 136,245株 | +9.66% | 79,706株 | +5.59% | 157,383株 | +16.14% | 42,508株 | +1.11% |
2019/10/04 | 日証協 | 124,239株 | +1.05% | 75,488株 | +109.69% | 135,506株 | +25.3% | 42,040株 | +10.3% |
2019/09/27 | 日証協 | 122,945株 | +1.91% | 36,000株 | -28.97% | 108,146株 | +0.58% | 38,115株 | +56.11% |
2019/09/20 | 日証協 | 120,645株 | -0.75% | 50,684株 | -0.94% | 107,527株 | -5.87% | 24,416株 | -28.93% |
2019/09/13 | 日証協 | 121,561株 | +23.98% | 51,164株 | -13.72% | 114,232株 | +4.98% | 34,356株 | -13.94% |
2019/09/06 | 日証協 | 98,045株 | -11.39% | 59,300株 | +35.08% | 108,811株 | -1.85% | 39,922株 | +84.57% |
2019/08/30 | 日証協 | 110,645株 | -15.7% | 43,900株 | +111.52% | 110,862株 | +20.93% | 21,630株 | +66.13% |
2019/08/23 | 日証協 | 131,245株 | -14.3% | 20,755株 | +25.79% | 91,673株 | -15.94% | 13,020株 | -14.36% |
2019/08/16 | 日証協 | 153,145株 | +2% | 16,500株 | -40.48% | 109,061株 | +14.26% | 15,203株 | -37.48% |
2019/08/09 | 日証協 | 150,145株 | +26.75% | 27,722株 | -53.95% | 95,451株 | +28.2% | 24,318株 | -34.66% |
※株式分割は考慮していませんのでご注意ください。
Page Top